Filed: 2/13/2024ACC: 0000904454-24-000134
📋 What this filing means
FINEPOINT CAPITAL LP filed this quarterly 13F‑HR report disclosing 27 equity positions with a total reported market value of $316.97M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
27
Positions
$316.97M
Total AUM (reported)
17.16M
Total Shares
Allocation by class
COM$187.67M59.2%
COM NEW$42.13M13.3%
SPONSORED ADR$20.63M6.5%
*W EXP 09/30/202$20.01M6.3%
SPON ADR$18.64M5.9%
COM SER C$14.87M4.7%
SHS$12.69M4.0%
Portfolio Concentration
Top 3$88.00M27.8%
4–10$139.21M43.9%
11–25$89.72M28.3%
Rest$33.4K0.0%
Top 3 weight
27.8%
Top 10 weight
71.7%
Voting Authority Distribution
Total shares with voting rights: 17.16M
Sole
Full voting authority
17.16M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole27
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings27
Rows:
CYTOKINETICS INC
SOLEShares431.69K
TypeSH
Market value$36.04M
11.37%
Sole
431.69K
Shared
0.00
None
0.00
SPIRIT AIRLINES INC
SOLEShares1.70M
TypeSH
Market value$27.86M
8.79%
Sole
1.70M
Shared
0.00
None
0.00
ACADIA PHARMACEUTICALS INC
SOLEShares769.65K
TypeSH
Market value$24.10M
7.60%
Sole
769.65K
Shared
0.00
None
0.00
AMICUS THERAPEUTICS INC
SOLEShares1.49M
TypeSH
Market value$21.13M
6.67%
Sole
1.49M
Shared
0.00
None
0.00
ARVINAS INC
SOLEShares504.70K
TypeSH
Market value$20.77M
6.55%
Sole
504.70K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares163.77K
TypeSH
Market value$20.63M
6.51%
Sole
163.77K
Shared
0.00
None
0.00
SPRINGWORKS THERAPEUTICS INC
SOLEShares556.93K
TypeSH
Market value$20.33M
6.41%
Sole
556.93K
Shared
0.00
None
0.00
HOME PLATE ACQUISITION CORP
SOLEShares331.42K
TypeSH
Market value$20.01M
6.31%
Sole
331.42K
Shared
0.00
None
0.00
GALAPAGOS NV
SOLEShares458.66K
TypeSH
Market value$18.64M
5.88%
Sole
458.66K
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares617.10K
TypeSH
Market value$17.70M
5.58%
Sole
617.10K
Shared
0.00
None
0.00
LIBERTY BROADBAND CORP
SOLEShares184.46K
TypeSH
Market value$14.87M
4.69%
Sole
184.46K
Shared
0.00
None
0.00
RELAY THERAPEUTICS INC
SOLEShares1.32M
TypeSH
Market value$14.51M
4.58%
Sole
1.32M
Shared
0.00
None
0.00
MORPHIC HOLDING INC
SOLEShares496.86K
TypeSH
Market value$14.35M
4.53%
Sole
496.86K
Shared
0.00
None
0.00
SAREPTA THERAPEUTICS INC
SOLEShares145.36K
TypeSH
Market value$14.02M
4.42%
Sole
145.36K
Shared
0.00
None
0.00
TRAVERE THERAPEUTICS INC
SOLEShares1.44M
TypeSH
Market value$12.90M
4.07%
Sole
1.44M
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares349.30K
TypeSH
Market value$12.69M
4.00%
Sole
349.30K
Shared
0.00
None
0.00
SOLID BIOSCIENCES INC
SOLEShares961.25K
TypeSH
Market value$5.90M
1.86%
Sole
961.25K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares125K
TypeSH
Market value$188.8K
0.06%
Sole
125K
Shared
0.00
None
0.00
CHURCHILL CAPITAL CORP VII
SOLEShares548K
TypeSH
Market value$71.3K
0.02%
Sole
548K
Shared
0.00
None
0.00
MOONLAKE IMMUNOTHERAPEUTICS
SOLEShares895K
TypeSH
Market value$62.7K
0.02%
Sole
895K
Shared
0.00
None
0.00
CONCORD ACQUISITION CORP II
SOLEShares408.33K
TypeSH
Market value$53.1K
0.02%
Sole
408.33K
Shared
0.00
None
0.00
CALIDI BIOTHERAPEUTICS INC
SOLEShares655.20K
TypeSH
Market value$32.8K
0.01%
Sole
655.20K
Shared
0.00
None
0.00
ROSS ACQUISITION CORP II
SOLEShares439.67K
TypeSH
Market value$24.6K
<0.01%
Sole
439.67K
Shared
0.00
None
0.00
COMPASS DIGITAL ACQUISITION CORP
SOLEShares459.91K
TypeSH
Market value$22.3K
<0.01%
Sole
459.91K
Shared
0.00
None
0.00
MARBLEGATE ACQUISITION CORP
SOLEShares735K
TypeSH
Market value$22.1K
<0.01%
Sole
735K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
CYTOKINETICS INCSOLE | COM NEW | 431.69K | SH | $36.04M 11.37% | 431.69K | 0.00 | 0.00 |
SPIRIT AIRLINES INCSOLE | COM | 1.70M | SH | $27.86M 8.79% | 1.70M | 0.00 | 0.00 |
ACADIA PHARMACEUTICALS INCSOLE | COM | 769.65K | SH | $24.10M 7.60% | 769.65K | 0.00 | 0.00 |
AMICUS THERAPEUTICS INCSOLE | COM | 1.49M | SH | $21.13M 6.67% | 1.49M | 0.00 | 0.00 |
ARVINAS INCSOLE | COM | 504.70K | SH | $20.77M 6.55% | 504.70K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 163.77K | SH | $20.63M 6.51% | 163.77K | 0.00 | 0.00 |
SPRINGWORKS THERAPEUTICS INCSOLE | COM | 556.93K | SH | $20.33M 6.41% | 556.93K | 0.00 | 0.00 |
HOME PLATE ACQUISITION CORPSOLE | *W EXP 09/30/202 | 331.42K | SH | $20.01M 6.31% | 331.42K | 0.00 | 0.00 |
GALAPAGOS NVSOLE | SPON ADR | 458.66K | SH | $18.64M 5.88% | 458.66K | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 617.10K | SH | $17.70M 5.58% | 617.10K | 0.00 | 0.00 |
LIBERTY BROADBAND CORPSOLE | COM SER C | 184.46K | SH | $14.87M 4.69% | 184.46K | 0.00 | 0.00 |
RELAY THERAPEUTICS INCSOLE | COM | 1.32M | SH | $14.51M 4.58% | 1.32M | 0.00 | 0.00 |
MORPHIC HOLDING INCSOLE | COM | 496.86K | SH | $14.35M 4.53% | 496.86K | 0.00 | 0.00 |
SAREPTA THERAPEUTICS INCSOLE | COM | 145.36K | SH | $14.02M 4.42% | 145.36K | 0.00 | 0.00 |
TRAVERE THERAPEUTICS INCSOLE | COM | 1.44M | SH | $12.90M 4.07% | 1.44M | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 349.30K | SH | $12.69M 4.00% | 349.30K | 0.00 | 0.00 |
SOLID BIOSCIENCES INCSOLE | COM NEW | 961.25K | SH | $5.90M 1.86% | 961.25K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | COM NEW | 125K | SH | $188.8K 0.06% | 125K | 0.00 | 0.00 |
CHURCHILL CAPITAL CORP VIISOLE | *W EXP 02/29/202 | 548K | SH | $71.3K 0.02% | 548K | 0.00 | 0.00 |
MOONLAKE IMMUNOTHERAPEUTICSSOLE | CLASS A ORD | 895K | SH | $62.7K 0.02% | 895K | 0.00 | 0.00 |
CONCORD ACQUISITION CORP IISOLE | *W EXP 99/99/999 | 408.33K | SH | $53.1K 0.02% | 408.33K | 0.00 | 0.00 |
CALIDI BIOTHERAPEUTICS INCSOLE | *W EXP 03/14/202 | 655.20K | SH | $32.8K 0.01% | 655.20K | 0.00 | 0.00 |
ROSS ACQUISITION CORP IISOLE | *W EXP 02/01/202 | 439.67K | SH | $24.6K <0.01% | 439.67K | 0.00 | 0.00 |
COMPASS DIGITAL ACQUISITION CORPSOLE | *W EXP 09/29/202 | 459.91K | SH | $22.3K <0.01% | 459.91K | 0.00 | 0.00 |
MARBLEGATE ACQUISITION CORPSOLE | *W EXP 08/31/202 | 735K | SH | $22.1K <0.01% | 735K | 0.00 | 0.00 |
Page 1 of 2